Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Abstract Ahead of Print

Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer

Volume:19
Tatsuya Nagano*, Motoko Tachihara and Yoshihiro Nishimura

Mesoporous silica nanoparticles as a prospective and promising approach for drug delivery and biomedical applications

Volume:19
Xiaohui Pu, Jia Li, Peng Qiao, Mengmeng Li, Haiyan Wang, Lanlan Zong*, Qi Yuan and Shaofeng Duan*

Overexpression of Nemo-like kinase promotes the proliferation and invasion of lung cancer cells and indicates poor prognosis

Volume:18
Lei Lei, Yuan Wang, Yi-Wen Zheng, Liang-Ru Fei, Hao-Yue Shen, Zhi-Han Li, Wen-Jing Huang, Juan-Han Yu and Hong-Tao Xu

HSF1 as a Cancer Biomarker and Therapeutic Target

Volume:18
Richard L. Carpenter* and Yesim Gokmen-Polar